The question to open with
A pharmacy or clinician uses compounding to prepare medicine to order.
As of September 2026, BPC-157 does not meet the federal rules for ingredients an ordinary pharmacy may use to make a medicine to order.
These are rules about permission to use an ingredient, rather than tests run in a lab. Ask the clinician to explain which rule they believe allows the offer.
Is the pharmacy allowed to make this BPC-157 medicine for me, and which rule allows it?
Check the claim against the dated record
The rules for an ordinary pharmacy
As of September 2026, the pharmacy must follow an official written drug standard for a raw ingredient if one exists.
If no official drug standard exists, the ingredient must appear in a medicine approved by the FDA.
If neither of those conditions is met, the ingredient must be on the FDA’s official list of extra ingredients allowed for compounding.
Documents from the FDA, the US medicine regulator, show BPC-157 meets none of these conditions, as of September 2026.
Requests that were taken back
The groups seeking FDA permission for pharmacies to use BPC-157 withdrew those requests.
The FDA page lists BPC-157 among the requests taken back and is marked current on April 22, 2026.
Taking those requests back did not give BPC-157 approval or permission for use under the ingredient rules, as of September 2026.
Advice about changing the list
In July 2026, FDA staff advised keeping BPC-157 out of the list of extra ingredients ordinary pharmacies may use.
The FDA’s Pharmacy Compounding Advisory Committee met to advise the FDA about ingredients for medicines made to order.
A check of the FDA’s published records on September 28, 2026 found no record showing how that committee voted.
The missing record leaves the vote’s outcome unclear.
As of September 2026, even a yes vote would only be advice; changing the list requires the FDA to change the rule and invite public comments.
Ask the clinician to explain the rule in the dated official document.
Keep the care discussion open
A visit can still be used to discuss the health concern that led you here. Ask about other options, what an assessment could find and what evidence applies.
If the reply cites a headline, ask for the FDA document and its date. Ask the clinician to explain how it answers your question about permission to make the medicine.
Open the source drawer
These links open the documents used for this page. Ask the clinician to show you the part that supports their answer and explain anything unclear.